| Outcome Measures: |
Primary: Change in GLP-1, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes | Secondary: Change in insulin, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in C-peptide, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in glucagon, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in glucagon-like-peptide 2 (GLP-2), At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in glucose-dependent insulinotropic polypeptide (GIP), At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in peptide YY (PYY), At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in oxyntomodulin, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in bile acids, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in gastrin, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in CCK, At baseline, and at 5, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150 and 180 minutes|Change in appetite, satiety and prospective food consumption, Evaluated by Visual Analog Scale (VAS), At baseline, and 30, 60, 90, 120 and 180 minutes|Change in gallbladder volume, Evaluated by ultrasound, -30, 0 (baseline), 30, 60, 120 og 180 minutes|Change in basal metabolic rate, Evaluated by indirect calorimetry, At -30, 60 og 150 minutes|Change in bile acid composition, Evaluated by duodenal aspiration, At -30, 0, 30, 60, 120 og 180 minutes
|
